Product Code: ETC10597902 | Publication Date: Apr 2025 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The human albumin market in India is experiencing steady growth due to factors such as increasing prevalence of chronic diseases, rising demand for albumin in critical care settings, and expanding healthcare infrastructure. Human albumin, a vital protein component in blood plasma, is widely used in the treatment of conditions like liver cirrhosis, burns, and sepsis. With the Indian government`s focus on improving healthcare access and affordability, the market is expected to further expand. Key players in the India human albumin market include Bharat Serums and Vaccines Ltd., Reliance Life Sciences, and Albert David Ltd. The market is also witnessing advancements in albumin production techniques and the introduction of innovative albumin products, contributing to its growth trajectory.
The human albumin market in India is witnessing several key trends. One prominent trend is the increasing demand for human albumin in critical care settings, such as in the treatment of severe infections, liver diseases, and trauma cases. Another trend is the rising adoption of human albumin in cosmetic procedures, particularly in dermatology and plastic surgery, for its skin rejuvenation properties. Additionally, the market is experiencing a shift towards the use of recombinant human albumin over traditional plasma-derived albumin due to its perceived safety and efficacy benefits. Moreover, the growing prevalence of chronic conditions like cirrhosis and kidney diseases is expected to drive the demand for human albumin in the coming years. Overall, the India human albumin market is poised for significant growth driven by these evolving trends.
The human albumin market in India faces several challenges, including increasing competition from alternative therapies, such as synthetic colloids, which offer similar benefits at a lower cost. Additionally, the high cost of human albumin products and the limited availability of donor plasma for production pose challenges for market growth. Regulatory hurdles and stringent quality requirements for albumin production also contribute to the challenges faced by companies operating in this market. Furthermore, the lack of awareness among healthcare professionals and patients about the benefits of human albumin therapy hinders market expansion. To overcome these challenges, companies in the India human albumin market need to focus on innovation, cost-effective production techniques, and educational initiatives to increase adoption and drive market growth.
Investment opportunities in the India human albumin market are promising due to the increasing demand for albumin in various medical applications such as treating shock, burns, liver disease, and other conditions. The market is expected to grow significantly in the coming years, driven by factors such as a rising geriatric population, increasing healthcare expenditure, and advancements in healthcare infrastructure. Investing in the production and distribution of human albumin products, as well as research and development for new applications, could be lucrative opportunities for investors looking to capitalize on the growing healthcare sector in India. Additionally, partnerships with hospitals, clinics, and pharmaceutical companies can help expand market reach and create a competitive edge in this growing market segment.
In India, the government regulates the human albumin market through the Drug Controller General of India (DCGI) which oversees the approval, manufacturing, pricing, and distribution of human albumin products. The government has implemented policies to ensure the quality, safety, and efficacy of human albumin, as well as to prevent price gouging and ensure affordability for patients. The DCGI mandates that human albumin products must comply with the standards set by the Pharmacopoeia and other regulatory requirements to be approved for sale in the market. Additionally, the National Pharmaceutical Pricing Authority (NPPA) monitors and regulates the prices of essential medicines, including human albumin, to make them accessible to the general public. Overall, these government policies aim to maintain a balance between ensuring high-quality human albumin products are available while also keeping them affordable for patients in need.
The India human albumin market is expected to experience steady growth in the coming years, driven by factors such as increasing prevalence of chronic diseases, rising number of surgeries, and growing awareness about the benefits of albumin in medical treatment. With the expanding healthcare infrastructure and rising healthcare expenditure in the country, the demand for human albumin is likely to rise. Additionally, advancements in healthcare technology and increasing research and development activities in the pharmaceutical sector are expected to further boost market growth. However, factors such as stringent regulatory requirements and the availability of alternative treatment options may pose challenges to market expansion. Overall, the India human albumin market is anticipated to witness sustained growth in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Human Albumin Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Human Albumin Market Revenues & Volume, 2021 & 2031F |
3.3 India Human Albumin Market - Industry Life Cycle |
3.4 India Human Albumin Market - Porter's Five Forces |
3.5 India Human Albumin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Human Albumin Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 India Human Albumin Market Revenues & Volume Share, By Purity Level, 2021 & 2031F |
3.8 India Human Albumin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 India Human Albumin Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
4 India Human Albumin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Human Albumin Market Trends |
6 India Human Albumin Market, By Types |
6.1 India Human Albumin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Human Albumin Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India Human Albumin Market Revenues & Volume, By Human Albumin, 2021 - 2031F |
6.1.4 India Human Albumin Market Revenues & Volume, By Recombinant, 2021 - 2031F |
6.1.5 India Human Albumin Market Revenues & Volume, By Plasma-derived, 2021 - 2031F |
6.1.6 India Human Albumin Market Revenues & Volume, By Human-based, 2021 - 2031F |
6.2 India Human Albumin Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 India Human Albumin Market Revenues & Volume, By Plasma, 2021 - 2031F |
6.2.3 India Human Albumin Market Revenues & Volume, By Recombinant, 2021 - 2031F |
6.2.4 India Human Albumin Market Revenues & Volume, By Plasma, 2021 - 2031F |
6.2.5 India Human Albumin Market Revenues & Volume, By Blood Plasma, 2021 - 2031F |
6.3 India Human Albumin Market, By Purity Level |
6.3.1 Overview and Analysis |
6.3.2 India Human Albumin Market Revenues & Volume, By 98%+, 2021 - 2031F |
6.3.3 India Human Albumin Market Revenues & Volume, By >99%, 2021 - 2031F |
6.3.4 India Human Albumin Market Revenues & Volume, By 95%+, 2021 - 2031F |
6.3.5 India Human Albumin Market Revenues & Volume, By 1, 2021 - 2031F |
6.4 India Human Albumin Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Human Albumin Market Revenues & Volume, By Critical Care, 2021 - 2031F |
6.4.3 India Human Albumin Market Revenues & Volume, By Immune Deficiencies, 2021 - 2031F |
6.4.4 India Human Albumin Market Revenues & Volume, By Burns, 2021 - 2031F |
6.4.5 India Human Albumin Market Revenues & Volume, By Liver Diseases, 2021 - 2031F |
6.5 India Human Albumin Market, By Dosage Form |
6.5.1 Overview and Analysis |
6.5.2 India Human Albumin Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.5.3 India Human Albumin Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.4 India Human Albumin Market Revenues & Volume, By Infusion, 2021 - 2031F |
6.5.5 India Human Albumin Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
7 India Human Albumin Market Import-Export Trade Statistics |
7.1 India Human Albumin Market Export to Major Countries |
7.2 India Human Albumin Market Imports from Major Countries |
8 India Human Albumin Market Key Performance Indicators |
9 India Human Albumin Market - Opportunity Assessment |
9.1 India Human Albumin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Human Albumin Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 India Human Albumin Market Opportunity Assessment, By Purity Level, 2021 & 2031F |
9.4 India Human Albumin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 India Human Albumin Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
10 India Human Albumin Market - Competitive Landscape |
10.1 India Human Albumin Market Revenue Share, By Companies, 2024 |
10.2 India Human Albumin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |